No black box warning on record for Emrelis
As of the latest FDA labeling reviewed, Emrelis (TELISOTUZUMAB VEDOTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Emrelis medicine page for the complete safety profile.